UDCA/BDD Complex and Omega-3 Fatty Acids Attenuate Diet-Induced Hepatic Steatosis in Mice: A Serial Ultrasonography and Histology Study

Background/Objectives: Ursodeoxycholic acid (UDCA) and omega-3 fatty acids act on partly distinct hepatic pathways, but their effects on steatotic liver disease remain understudied. We evaluated a UDCA/biphenyl dimethyl dicarboxylate (BDD) complex and omega-3 fatty acids, alone and combined, in mice with high-fat diet-induced hepatic steatosis. Methods: Male C57BL/6J mice were fed a high-fat diet for 8 weeks and then gavaged 6 days per week with vehicle, UDCA/BDD complex, omega-3, or both for 12 weeks on the same diet. Steatosis was graded by ultrasonography every 4 weeks. Histology, immunohistochemistry, serum biochemistry, and targeted quantitative real-time polymerase chain reaction (qPCR) were assessed at the end of treatment. Hepatic transcriptome data from one animal per group are provided as supplementary exploratory data. Results: Ultrasonographic steatosis grades were lower in all treatment groups, and histological steatosis was lowest with UDCA/BDD (p = 0.031 versus Control), without ballooning or relevant fibrosis. Serum aspartate aminotransferase was lowest with the combination, with a significant omega-3 effect and no detectable interaction. The stearoyl-CoA desaturase 1 (SCD1) immunohistochemical score was lower in all treatment groups than in Control. The reduction in Scd1 mRNA in the combination group was nominal and did not persist after multiple-testing correction. Conclusions: The UDCA/BDD complex and omega-3 fatty acids, alone or combined, were associated with lower ultrasonographic and histological steatosis. The combination was numerically favorable for some outcomes but was not superior to monotherapy, and no statistically significant interaction was detected. These findings support further evaluation in models of steatohepatitis and fibrosis.

Authors

Institutions

Publication Details

Journal
Pharmaceuticals
Published
2026-11-19
DOI
https://doi.org/10.3390/ph19111842
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

UDCA/BDD Complex and Omega-3 Fatty Acids Attenuate Diet-Induced Hepatic Steatosis in Mice: A Serial Ultrasonography and Histology Study

Jae Hee Cho, Sung Ill Jang, 원광식, Sung Hwan Yoo et al.
Pharmaceuticals
Liver Disease Diagnosis and Treatment
article

UDCA/BDD Complex and Omega-3 Fatty Acids Attenuate Diet-Induced Hepatic Steatosis in Mice: A Serial Ultrasonography and Histology Study

Jae Hee Cho, Sung Ill Jang, 원광식, Sung Hwan Yoo, Jung Il Lee, Sungsoon Fang, Ji Hae Nahm, Hyun Woong Lee, Su Yeon Lee, Yeonsoo Oh, Chae Eun Jang, Youngmi Song, Minjin Sung, So Jeong Kim, Jaesun Cha, SangHyun Park, See Young Lee
article en

Abstract

Background/Objectives: Ursodeoxycholic acid (UDCA) and omega-3 fatty acids act on partly distinct hepatic pathways, but their effects on steatotic liver disease remain understudied. We evaluated a UDCA/biphenyl dimethyl dicarboxylate (BDD) complex and omega-3 fatty acids, alone and combined, in mice with high-fat diet-induced hepatic steatosis. Methods: Male C57BL/6J mice were fed a high-fat diet for 8 weeks and then gavaged 6 days per week with vehicle, UDCA/BDD complex, omega-3, or both for 12 weeks on the same diet. Steatosis was graded by ultrasonography every 4 weeks. Histology, immunohistochemistry, serum biochemistry, and targeted quantitative real-time polymerase chain reaction (qPCR) were assessed at the end of treatment. Hepatic transcriptome data from one animal per group are provided as supplementary exploratory data. Results: Ultrasonographic steatosis grades were lower in all treatment groups, and histological steatosis was lowest with UDCA/BDD (p = 0.031 versus Control), without ballooning or relevant fibrosis. Serum aspartate aminotransferase was lowest with the combination, with a significant omega-3 effect and no detectable interaction. The stearoyl-CoA desaturase 1 (SCD1) immunohistochemical score was lower in all treatment groups than in Control. The reduction in Scd1 mRNA in the combination group was nominal and did not persist after multiple-testing correction. Conclusions: The UDCA/BDD complex and omega-3 fatty acids, alone or combined, were associated with lower ultrasonographic and histological steatosis. The combination was numerically favorable for some outcomes but was not superior to monotherapy, and no statistically significant interaction was detected. These findings support further evaluation in models of steatohepatitis and fibrosis.

PharmaceuticalsVol. 19(11)
Ewha Womans University (KR), Yonsei University (KR), Taewoong Medical (South Korea) (KR), Kangbuk Samsung Hospital (KR), Gangnam Severance Hospital (KR), Ewha Womans University Seoul Hospital (KR), Pusan National University (KR), Sungkyunkwan University (KR)
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon